
    
      1. Disease specific inclusion criteria:

             -  Histologically documented gastricadenocarcinoma with Lauren classification
                Clinically diagnosed stage T2-3/N+M0,orT4aN+M0 according to CT/MRI scan, and
                resectable

             -  Measurable disease is required

             -  Karnofsky score 80%.

             -  Physical condition and adequate organ function to ensure the success of abdominal
                surgery.

             -  Life expectancy ≥12 weeks.

             -  Adequate hematological function: Neutrophil count ≥ 1.5 × 109/L, Platelets ≥ 100 ×
                109/L and Hemoglobin ≥8g/dL .Adequate liver function: Total bilirubin ≤ 1.5 × upper
                limit of normal (ULN); AST (SGOT) and ALT (SGPT) < 2.5 × ULN in the absence of
                liver metastases, or < 5 × ULN in case of liver metastases. ALP ≤ 2.5 × upper limit
                of normal (ULN); ALB ≥30g/L.

           Adequate renal function: Serum creatinine ≤ 1.25 x ULN, and creatinine clearance ≥ 60
           ml/min.

             -  Female subjects should not be pregnant or breast-feeding.

             -  No serious concomitant disease that will threaten the survival of patients to less
                than 5 years.

        2. General inclusion criteria:

             -  Male or female. Age ≥ 18 years and ≤75 years

             -  Written (signed) informed consent.

             -  Able to comply with study and follow-up procedures.

             -  Good compliance with the treatment plan。

             -  Consent to provide tissue sample。
    
  